Brief: Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes
Sept 8 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A: LINEAGE CELL THERAPEUTICS INITIATES CELL TRANSPLANT PROGRAM IN TYPE 1 DIABETES Source text: ID:nBwb4CvZSa Further company coverage: LCTX.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million